» Articles » PMID: 22256336

The Incidence and Correlates of Symptomatic and Asymptomatic Chlamydia Trachomatis and Neisseria Gonorrhoeae Infections in Selected Populations in Five Countries

Overview
Journal Sex Transm Dis
Date 2012 Jan 19
PMID 22256336
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Asymptomatic Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhea) infections pose diagnostic and control problems in developing countries.

Methods: Participants in China, India, Peru, Russia, and Zimbabwe were screened for C. trachomatis and N. gonorrhoeae infections and symptoms.

Results: A total of 18,014 participants were evaluated at baseline, 15,054 at 12 months, and 14,243 at 24 months. The incidence of chlamydia in men was 2.0 per 100 person years both from baseline to 12 months and from 12 to 24 months, and in women, 4.6 from baseline to 12 months and 3.6 from 12 to 24 months; a range of 31.2% to 100% reported no symptoms across the 5 countries. The incidence of gonorrhea in men was 0.3 per 100 person years both from baseline to 12 months and from 12 to 24 months, and in women, 1.4 from baseline to 12 months and 1.1 from 12 to 24 months; a range of 66.7% to 100% reported no symptoms. Being female, aged 18 to 24 years, and having more than 1 partner were associated with both the infections. In addition, being divorced, separated, or widowed was associated with gonorrhea. Being male, having 6+ years of education, and reporting only 1 partner were associated with having no symptoms among those infected with chlamydia. No variables correlated with asymptomatic gonorrhea among those infected.

Conclusion: A high prevalence and incidence of asymptomatic sexually transmitted infections was identified among men and women in a wide variety of settings. More effective programs are needed to identify and treat chlamydia and gonorrhea infections, especially among women, young adults, those with multiple partners, those repeatedly infected, and particularly those at risk without symptoms. The risk of transmission from persons with no symptoms requires further study.

Citing Articles

Enhanced and Sexually Transmitted Infections and Associated Risk Factors in Fiji Following the Coronavirus Disease 2019 Pandemic.

Auchus I, Brown J, Kama M, Vargo S, Devi R, Singh J Open Forum Infect Dis. 2025; 12(3):ofaf101.

PMID: 40046883 PMC: 11881064. DOI: 10.1093/ofid/ofaf101.


Neisseria gonorrhoeae induces local secretion of IL-10 at the human cervix to promote colonization.

Dai Y, Edwards V, Yu Q, Tettelin H, Stein D, Song W J Clin Invest. 2024; 135(2.

PMID: 39585777 PMC: 11735093. DOI: 10.1172/JCI183331.


Relationship between Chlamydia Trachomatis infection, infertility, and serum 25-hydroxyvitamin D: a cross-sectional study from NHANES 2013-2016.

Na M, Zeng L, Sun X, Huang Y, Lin M, Zhi X J Health Popul Nutr. 2024; 43(1):186.

PMID: 39538249 PMC: 11562478. DOI: 10.1186/s41043-024-00681-6.


Performance Evaluation of the LabGenius C-CT/NG-BMX Assay for and Detection.

Lim Y, Kweon O, Park A, Kim H, Yoon S, Kim T Ann Lab Med. 2024; 45(2):218-222.

PMID: 39511934 PMC: 11788701. DOI: 10.3343/alm.2024.0118.


Inc Ct226 is vital for FLI1 and LRRF1 recruitment to the chlamydial inclusion.

Sturd N, Knight L, Wood M, Durham L, Ouellette S, Rucks E mSphere. 2024; 9(11):e0047324.

PMID: 39404459 PMC: 11580450. DOI: 10.1128/msphere.00473-24.


References
1.
McCormack W, Stumacher R, Johnson K, Donner A . Clinical spectrum of gonococcal infection in women. Lancet. 1977; 1(8023):1182-5. DOI: 10.1016/s0140-6736(77)92720-9. View

2.
Potterat J, Dukes R, Rothenberg R . Disease transmission by heterosexual men with gonorrhea: an empiric estimate. Sex Transm Dis. 1987; 14(2):107-10. DOI: 10.1097/00007435-198704000-00010. View

3.
Geisler W, Wang C, Morrison S, Black C, Bandea C, Hook 3rd E . The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis. 2007; 35(2):119-23. DOI: 10.1097/OLQ.0b013e318151497d. View

4.
. Methodological overview of a five-country community-level HIV/sexually transmitted disease prevention trial. AIDS. 2007; 21 Suppl 2:S3-18. DOI: 10.1097/01.aids.0000266453.18644.27. View

5.
. Results of the NIMH collaborative HIV/sexually transmitted disease prevention trial of a community popular opinion leader intervention. J Acquir Immune Defic Syndr. 2010; 54(2):204-14. PMC: 2904551. DOI: 10.1097/QAI.0b013e3181d61def. View